Novel agents for advanced pancreatic cancer - Wikidata - awgldk - TriplyDB

Novel agents for advanced pancreatic cancer

Novel agents for advanced pancreatic cancer

http://www.wikidata.org/entity/Q26787087

about

Novel regulatory role of neuropilin-1 in endothelial-to-mesenchymal transition and fibrosis in pancreatic ductal adenocarcinoma Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer.A varying-coefficient cox model for the effect of CA19-9 kinetics on overall survival in patients with advanced pancreatic cancer Natural Products as Adjunctive Treatment for Pancreatic Cancer: Recent Trends and Advancements.Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer.Challenges and Opportunities in Modeling Pancreatic Cancer.Establishment of prostate cancer spheres from a prostate cancer cell line after phenethyl isothiocyanate treatment and discovery of androgen-dependent reversible differentiation between sphere and neuroendocrine cells A Phase II Study of Ganetespib as Second-line or Third-line Therapy for Metastatic Pancreatic Cancer.TGFβ1 overexpression is associated with improved survival and low tumor cell proliferation in patients with early-stage pancreatic ductal adenocarcinoma.MicroRNA-216b-5p Functions as a Tumor-suppressive RNA by Targeting TPT1 in Pancreatic Cancer Cells.EGFR-induced phosphorylation of type Iγ phosphatidylinositol phosphate kinase promotes pancreatic cancer progression.

P2860

Q30360377-1198D593-E77A-4E9E-B713-9B2B110A786F Q33429758-0D81C1A0-4841-4FEF-87A2-0C434D35E247 Q33728198-65DA87DC-2F81-4744-805D-58BF1DD2E0CD Q37625297-0853A257-3F3D-49FE-AB0A-0D2DD8D679A0 Q37741161-0C04AB6C-FCEC-4232-8D21-24C787CC4303 Q38746419-76BDE493-BEF7-43C7-AD85-EB61E4BE9213 Q38781961-F8D8F692-4F7A-436E-B57F-B2A0229CF3C1 Q38903322-103E0870-8465-475F-BC05-C091CE745B99 Q39147303-CBB01E42-FA01-4D40-9E49-5ABAEBA9CC1A Q41721735-62D70F83-E1A5-4C9D-A11A-417DBDDB577E Q42109581-B1AC7EA1-9E6C-454B-9A67-903D7360458F

P2860

Novel agents for advanced pancreatic cancer

http://www.wikidata.org/entity/Q26787087

description

2015 nî lūn-bûn

@nan

2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Novel agents for advanced pancreatic cancer

@ast

Novel agents for advanced pancreatic cancer

@en

Novel agents for advanced pancreatic cancer

@nl

type

label

Novel agents for advanced pancreatic cancer

@ast

Novel agents for advanced pancreatic cancer

@en

Novel agents for advanced pancreatic cancer

@nl

prefLabel

Novel agents for advanced pancreatic cancer

@ast

Novel agents for advanced pancreatic cancer

@en

Novel agents for advanced pancreatic cancer

@nl

P1433

Q26787087-6F3824D8-7800-41ED-9219-CBBC231022AD

P1476

Q26787087-4DA23F6B-AFFE-4429-80AA-888A3D436669

P2093

Q26787087-184DA10A-6894-4CFC-96ED-1A1834746F64

Q26787087-2092A02F-EC54-4CA4-AED4-C4F2186B69A2

Q26787087-7F5EB2F9-6FDD-4A03-8F12-6803579E66D6

Q26787087-D24A4D5E-646D-4989-801A-DC90EF38D645

P275

Q26787087-376B2CBA-C5D7-44C9-930D-F5D652265976

P2860

Q26787087-06C5834B-A902-4EDE-A481-E90E7AE963B8

Q26787087-0C969F56-A84D-4C03-890A-B62DE70B2919

Q26787087-0CA54BF4-D0F1-423A-9234-CB2C49823ED1

Q26787087-0E2C4704-C107-4E03-B616-8D0FF775440C

Q26787087-0E51595B-FD23-403D-B639-C28AC2FF782B

Q26787087-110C3FEE-75BD-49A9-A32F-4489AF5248C2

Q26787087-1149DC32-C4BE-46F9-9E5E-823635B008DF

Q26787087-116CCA84-ACEE-48C4-A5B3-8839464877D3

Q26787087-144C214E-A7E1-463B-BB5D-A16E12CE265A

Q26787087-150196F8-330C-4DA3-9DF6-0969BA304AE3

P304

Q26787087-F62988C9-F589-4903-80C9-30E1014E046F

P31

Q26787087-BC18F44D-100C-4546-9CC4-CBADAFFADF9F

P3181

Q26787087-A577D8B5-192D-4E61-9CEE-D74CBD60A0BF

P356

Q26787087-5649D14D-9A38-463D-B07D-6D927BDD4663

P407

Q26787087-C5A228EB-E6CF-4A2B-BB7F-0C6AD7D5C0B0

P433

Q26787087-16866312-C41D-46D3-9AB1-E20345F71F10

P478

Q26787087-9AABCE92-AC04-4612-B5FD-3F94790875D4

P50

Q26787087-24B9A6B9-1662-4473-9EAD-FB240E4C83AC

P5008

Q26787087-93015B52-CD6F-452F-9C88-585676DAFB8B

P577

Q26787087-2C574C81-B628-4EE1-AC51-1F8ED505E788

P5875

Q26787087-DF520316-387C-4579-B828-AE87FE3EDFC9

P698

Q26787087-6C06F695-60E0-47D5-9E1B-103B11F861E3

P921

Q26787087-2E334102-4FC4-474E-9398-8CA435DF627D

Q26787087-41A42AAB-BBA5-4AF2-BF10-CAF57BB2013E

Q26787087-6B564A45-8E0A-47BF-9EB4-0834598EC97A

Q26787087-C71A3DB5-D0A6-4F0F-8C92-D908D5AFBCA7

Q26787087-F8C95418-2646-4D8A-A1EF-06294145C07B

P932

Q26787087-42A0DF1C-CADE-4CD5-9816-0A79DD22AD27

P3181

P356

ONCOTARGET.3999

P1433

P1476

Novel agents for advanced pancreatic cancer

@en

P2093

Akintunde Akinleye

http://www.w3.org/2001/XMLSchema#string

Chaitanya Iragavarapu

http://www.w3.org/2001/XMLSchema#string

Delong Liu

http://www.w3.org/2001/XMLSchema#string

Shundong Cang

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.5 Unported

P2860

Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT

Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response

Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis

Distinctive effects of the carboxyl-terminal sequence of the insulin-like growth factor I receptor on its signaling functions

Integrated preclinical and clinical development of S-trans, trans-Farnesylthiosalicylic Acid (FTS, Salirasib) in pancreatic cancer

The pancreatic stellate cell: a star on the rise in pancreatic diseases

RDEA119/BAY 869766: a potent, selective, allosteric inhibitor of MEK1/2 for the treatment of cancer

Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers

A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas.

Cancer statistics, 2014

P304

39521-39537

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

5033472

http://www.w3.org/2001/XMLSchema#string

P356

10.18632/ONCOTARGET.3999

http://www.w3.org/2001/XMLSchema#string

P407

P433

37

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Muhammad Furqan

P5008

P577

2015-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282040730

http://www.w3.org/2001/XMLSchema#string

P698

26369833

http://www.w3.org/2001/XMLSchema#string

P921

pancreatic cancer

monoclonal antibody

pancreatic neoplasm

P932

4741843

http://www.w3.org/2001/XMLSchema#string